5 news items
Bruker Announces Pricing of Public Offering of Common Stock
BRKR
29 May 24
no commitment to revise or update any forward-looking statements in order to reflect events or circumstances that may change, except as required by law
Bruker Announces Public Offering of Common Stock
BRKR
29 May 24
expectations, estimates and assumptions regarding future events and are applicable only as of the dates of such statements. Bruker makes no commitment
Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference
BRKR
26 Apr 24
: "Bruker is committed to innovation in routine microbiology and infectious disease testing. This includes nearly universal microbial identification
Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research
BRKR
4 Apr 24
underscores the commitment of both companies to scientific excellence and their shared vision of advancing precision medicine through innovative
Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research
BRKR
4 Apr 24
offering."
This partnership underscores the commitment of both companies to scientific excellence
- Prev
- 1
- Next